H-Source Blog

How CVS/Aetna Will Affect Supply Chain Operations

CVS’ acquisition of Aetna for $70B will be transformative to healthcare. A successful integration of these two prominent organizations will usher in a new healthcare model, much-needed innovation intended to lower costs and offer quality healthcare...

by H-Source on 11/30/2018

New Opportunities for Supply Chain

John Kupice, CEO of H-Source, was recently interviewed by Future Tech Podcast on the new opportunities medical facilities have to reduce financial waste in supply chain while providing quality healthcare to their communities.

by H-Source on 11/28/2018

Leveling the "Paying" Field

Contract negotiations can make or break a healthcare facility in terms of business viability and profitability. Whether you are for-profit, nonprofit, governmental or private, the general idea is to, at the very least, cover fixed costs and avoid...

by H-Source on 11/26/2018

Flu Season is in Full Effect

Flu season is in full effect. Are you ready? The CDC estimates between 9.2 million and 35.6 million flu illnesses each year in the United States. While getting a flu shot is suggested, some people are too late to get it and may eventually get sick....

by H-Source on 11/13/2018

Cost Control And Collaboration

In an ideal world, a hospital would purchase only the products it needs and use every product it purchases. Unfortunately, we do not live in an ideal world, and every day, hospitals and surgery centers throw away expiring inventory that could have...

by H-Source on 11/01/2018

Excess Waste in Healthcare?

Is there any other sector or industry where wasting 25% of expenses is even remotely acceptable? I can’t think of one. Yet that’s our healthcare system in the U.S., and at a time when rural hospitals are closing, hospital profit margins are razor...

by H-Source on 10/26/2018

Win for Consumers: Increase in Generic Pharmaceuticals

Having troubles finding certain medications? The FDA has implemented the Drug Competition Action Plan. This plan means that certain brand name medications with no listed patents or exclusivities, are now encouraged to develop generic alternatives....

by H-Source on 10/10/2018